Intuitive Surgical, Inc. $ISRG Holdings Lifted by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 170,057 shares of the medical equipment provider’s stock after acquiring an additional 30,014 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Intuitive Surgical were worth $92,411,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. Cornerstone Advisors LLC grew its holdings in shares of Intuitive Surgical by 33.6% during the second quarter. Cornerstone Advisors LLC now owns 19,100 shares of the medical equipment provider’s stock valued at $10,379,000 after buying an additional 4,800 shares in the last quarter. Citizens Financial Group Inc. RI boosted its position in Intuitive Surgical by 63.9% during the 2nd quarter. Citizens Financial Group Inc. RI now owns 14,943 shares of the medical equipment provider’s stock worth $8,120,000 after acquiring an additional 5,827 shares during the period. Avantax Advisory Services Inc. grew its stake in Intuitive Surgical by 21.1% during the 2nd quarter. Avantax Advisory Services Inc. now owns 28,246 shares of the medical equipment provider’s stock valued at $15,349,000 after acquiring an additional 4,912 shares in the last quarter. LGT Capital Partners LTD. acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $30,583,000. Finally, MJP Associates Inc. ADV boosted its holdings in shares of Intuitive Surgical by 3.2% during the second quarter. MJP Associates Inc. ADV now owns 1,154 shares of the medical equipment provider’s stock worth $627,000 after purchasing an additional 36 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $549.51 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a market capitalization of $196.99 billion, a PE ratio of 72.69, a PEG ratio of 4.94 and a beta of 1.62. The business’s 50-day simple moving average is $482.51 and its 200-day simple moving average is $503.09.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the firm posted $1.84 EPS. The company’s revenue was up 22.9% on a year-over-year basis. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the transaction, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 116,164 shares of company stock valued at $61,916,172 in the last three months. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ISRG. Piper Sandler boosted their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. UBS Group set a $600.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Finally, Rothschild & Co Redburn raised their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.